All In MedTech

Device Trial Radar · NCT01885572

National, Multicenter PMS Study "Patient Reported Outcome" in Breast Reconstruction Following Mastectomy With TiLOOP Bra

National, Multicenter Post-market Surveillance Study "Patient Reported Outcome" in Breast Reconstruction Following Mastectomy With Titaniferously Coated Polypropylene Mesh (TiLOOP Bra)

Last checked: Nov 21, 2026Latest source record: Sep 20, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

267

Actual

Start

Nov 2013

Primary completion

Aug 2017

Study completion Jun 2021

Sponsor

Lead sponsor
Pfm Medical Mepro GmbhNot on our public-company list
Sponsor type
Industry
Collaborators
pfm medical gmbh
First posted
Jun 25, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This multicentre, non-randomised, observational clinical device investigation will be performed to obtain postmarketing information on the TiLOOP® Bra and in particular on the improvement of the patients' quality of life as well as on the rate of complications of the device under investigation. The objective of this clinical investigation is to establish the feasibility, efficacy and safety of the TiLOOP® Bra.

Conditions

  • Breast Reconstruction After Mastectomy

Interventions

  • TiLOOP BraDevice

    Titaniferously coated polypropylene mesh

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PROTime frame: 12 months after breast reconstruction

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Charite Campus Mitte and Benjamin Franklin

    Berlin, Germany

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.